AI life sciences company rMark Bio gathers $1.5 mln seed

Chicago and Seattle-based rMark Bio, a provider of AI solutions for life sciences companies, has raised $1.5 million in seed funding. Lincoln Park Capital led the round with participation from M25 Group, SaaS Ventures and MATH Venture Partners.

Source: Press Release

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!